Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, CCR | 2 | 2021 | 24 | 0.870 |
Why?
|
| Neutrophils | 1 | 2022 | 131 | 0.790 |
Why?
|
| Immunotherapy | 1 | 2022 | 95 | 0.780 |
Why?
|
| Receptors, Virus | 2 | 2016 | 21 | 0.650 |
Why?
|
| Receptors, Chemokine | 2 | 2016 | 70 | 0.630 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 88 | 0.580 |
Why?
|
| Andrographis | 1 | 2016 | 4 | 0.550 |
Why?
|
| Receptors, CXCR | 1 | 2016 | 6 | 0.540 |
Why?
|
| Receptors, CXCR3 | 1 | 2016 | 31 | 0.540 |
Why?
|
| Metalloproteases | 1 | 2015 | 16 | 0.520 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 312 | 0.520 |
Why?
|
| Diterpenes | 1 | 2016 | 92 | 0.510 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 110 | 0.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 807 | 0.470 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 358 | 0.470 |
Why?
|
| Epithelial Cells | 2 | 2018 | 384 | 0.450 |
Why?
|
| Cell Movement | 6 | 2019 | 571 | 0.410 |
Why?
|
| Cell Line, Tumor | 8 | 2019 | 2231 | 0.380 |
Why?
|
| Colonic Neoplasms | 3 | 2018 | 186 | 0.370 |
Why?
|
| Apoptosis | 5 | 2019 | 1398 | 0.330 |
Why?
|
| Neoplasm Metastasis | 3 | 2019 | 219 | 0.300 |
Why?
|
| Chemokines, CC | 2 | 2019 | 51 | 0.280 |
Why?
|
| Receptors, Scavenger | 2 | 2016 | 15 | 0.270 |
Why?
|
| Chemokines, CXC | 2 | 2016 | 35 | 0.260 |
Why?
|
| Prostatic Neoplasms | 3 | 2019 | 935 | 0.240 |
Why?
|
| Signal Transduction | 4 | 2021 | 1908 | 0.210 |
Why?
|
| Immunologic Factors | 1 | 2022 | 45 | 0.210 |
Why?
|
| Humans | 13 | 2022 | 37093 | 0.180 |
Why?
|
| Cell Proliferation | 4 | 2019 | 1198 | 0.180 |
Why?
|
| Chemokines | 2 | 2017 | 97 | 0.180 |
Why?
|
| Amyloid Precursor Protein Secretases | 2 | 2019 | 33 | 0.170 |
Why?
|
| Cytoskeleton | 2 | 2018 | 110 | 0.170 |
Why?
|
| Cell Survival | 3 | 2018 | 864 | 0.170 |
Why?
|
| Matrix Metalloproteinases | 1 | 2019 | 48 | 0.160 |
Why?
|
| Proanthocyanidins | 1 | 2018 | 3 | 0.160 |
Why?
|
| Adherens Junctions | 1 | 2018 | 8 | 0.160 |
Why?
|
| Ovary | 1 | 2019 | 108 | 0.160 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 275 | 0.160 |
Why?
|
| Tight Junctions | 1 | 2018 | 24 | 0.160 |
Why?
|
| Quercetin | 1 | 2018 | 45 | 0.150 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2018 | 147 | 0.150 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 1502 | 0.150 |
Why?
|
| Phosphoproteins | 1 | 2018 | 163 | 0.140 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2016 | 7 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 182 | 0.140 |
Why?
|
| Cytokines | 2 | 2017 | 602 | 0.140 |
Why?
|
| Receptors, CCR6 | 1 | 2016 | 3 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1039 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2018 | 928 | 0.140 |
Why?
|
| Azoxymethane | 1 | 2016 | 7 | 0.140 |
Why?
|
| Dictyostelium | 1 | 2016 | 48 | 0.140 |
Why?
|
| Dextran Sulfate | 1 | 2016 | 15 | 0.140 |
Why?
|
| Chemokine CXCL11 | 1 | 2016 | 7 | 0.140 |
Why?
|
| Cyclin B1 | 1 | 2016 | 16 | 0.140 |
Why?
|
| CDC2 Protein Kinase | 1 | 2016 | 17 | 0.140 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2016 | 12 | 0.140 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 27 | 0.140 |
Why?
|
| Cyclins | 1 | 2016 | 37 | 0.140 |
Why?
|
| Retinoblastoma Protein | 1 | 2016 | 27 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 31 | 0.130 |
Why?
|
| Membrane Proteins | 2 | 2019 | 517 | 0.130 |
Why?
|
| Cell Growth Processes | 1 | 2015 | 41 | 0.130 |
Why?
|
| ADAM Proteins | 1 | 2015 | 16 | 0.130 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 122 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 1 | 2016 | 105 | 0.130 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2016 | 132 | 0.130 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2016 | 172 | 0.120 |
Why?
|
| Histones | 1 | 2016 | 190 | 0.120 |
Why?
|
| Prostate | 1 | 2016 | 154 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 803 | 0.120 |
Why?
|
| Ethanol | 1 | 2016 | 192 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 307 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 229 | 0.110 |
Why?
|
| Plant Extracts | 1 | 2016 | 286 | 0.110 |
Why?
|
| Inflammation | 1 | 2016 | 618 | 0.100 |
Why?
|
| Disease Progression | 3 | 2019 | 601 | 0.090 |
Why?
|
| Drug Synergism | 2 | 2019 | 177 | 0.080 |
Why?
|
| Female | 4 | 2019 | 20969 | 0.070 |
Why?
|
| Male | 4 | 2019 | 20025 | 0.070 |
Why?
|
| Protein Transport | 2 | 2016 | 302 | 0.060 |
Why?
|
| Flow Cytometry | 2 | 2016 | 399 | 0.060 |
Why?
|
| Calcium | 2 | 2018 | 480 | 0.060 |
Why?
|
| Prognosis | 2 | 2018 | 739 | 0.060 |
Why?
|
| Models, Biological | 2 | 2017 | 677 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2019 | 1207 | 0.050 |
Why?
|
| Fluorouracil | 1 | 2018 | 34 | 0.040 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2018 | 7 | 0.040 |
Why?
|
| Intercellular Junctions | 1 | 2018 | 17 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2018 | 54 | 0.040 |
Why?
|
| Point Mutation | 1 | 2018 | 93 | 0.040 |
Why?
|
| Dogs | 1 | 2018 | 149 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 290 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2018 | 208 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2019 | 222 | 0.040 |
Why?
|
| RNA, Antisense | 1 | 2016 | 17 | 0.040 |
Why?
|
| Annexin A5 | 1 | 2016 | 26 | 0.040 |
Why?
|
| Propidium | 1 | 2016 | 19 | 0.040 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2016 | 22 | 0.040 |
Why?
|
| Fluorometry | 1 | 2016 | 17 | 0.040 |
Why?
|
| Cell Shape | 1 | 2016 | 35 | 0.040 |
Why?
|
| Chemokine CCL20 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Cytosol | 1 | 2016 | 93 | 0.030 |
Why?
|
| NAD | 1 | 2016 | 50 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2016 | 84 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2016 | 105 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2019 | 339 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2016 | 108 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 196 | 0.030 |
Why?
|
| Cell Death | 1 | 2016 | 267 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 251 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2016 | 212 | 0.030 |
Why?
|
| Glucose | 1 | 2016 | 230 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2016 | 326 | 0.030 |
Why?
|
| Antioxidants | 1 | 2018 | 416 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 502 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 173 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 626 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 435 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 623 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 1369 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 461 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 893 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2016 | 859 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 674 | 0.030 |
Why?
|
| Mitochondria | 1 | 2016 | 487 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 251 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1130 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 938 | 0.020 |
Why?
|
| Animals | 2 | 2018 | 15081 | 0.020 |
Why?
|
| Mice | 1 | 2016 | 5913 | 0.020 |
Why?
|